Binghe Xu

22PUBLICATIONS
31CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 24, 2025
Efficacy and safety of vascular-targeting agents in advanced soft tissue sarcoma: a systematic review and network meta-analysis.

Yan Wang, Hangcheng Xu, Qiang Sa

|Aug 27, 2025
Safety Profile and Predictors of Adverse Events of Incadronate Disodium in Treating Breast Cancer Patients with Bone Metastases: A Retrospective Study.

Shihan Zhou, Mingxia Jiang, Jiaxuan Liu

|Jan 29, 2025
Non-Luminal Disease Score for Everolimus in Patients with Hormone Receptor‑positive and Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Multicenter and Retrospective Study.

Yujing Tan, Hanfang Jiang, Xinzhu Tian

|Mar 14, 2024
Impact of HER2-low expression on the efficacy of endocrine therapy with or without CDK4/6 inhibitor in HR-positive/HER2-negative metastatic breast cancer: A prospective study.

Yun Wu, Hongnan Mo, Hangcheng Xu

|Dec 13, 2023
Advances in medical treatment of breast cancer in 2022.

Jingtong Zhai, Yun Wu, Fei Ma

|Oct 16, 2023
Eribulin combined with antiangiogenic agents in women with HER2-negative metastatic breast cancer: a retrospective multicenter study.

Mingxia Jiang, Bin Shao, Donggui Wan

Pageof 4

Frequent Collaborators

10 joint publications

Zongbi Yi

4 joint publications

Yiqun Han

4 joint publications

Qiao Li

3 joint publications

Zongbi Yi